Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 May 19];8(6):s480. Available from: https://skin.dermsquared.com/skin/article/view/3040